Journal
CELL DEATH AND DIFFERENTIATION
Volume 27, Issue 6, Pages 1795-1806Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41418-019-0459-6
Keywords
-
Categories
Ask authors/readers for more resources
Lung cancer is one of the cancers with highest morbidity and mortality rates and the metastasis of lung cancer is a leading cause of death. Mechanisms of lung cancer metastasis are yet to be fully understood. Herein, we demonstrate that mice deficient for REG gamma, a proteasome activator, exhibited a significant reduction in tumor size, numbers, and metastatic rate with prolonged survival in a conditional Kras/p53 mutant lung cancer model. REG gamma enhanced the TGF beta-Smad signaling pathway by ubiquitin-ATP-independent degradation of Smad7, an inhibitor of the TGF beta pathway. Activated TGF beta signaling in REG gamma-positive lung cancer cells led to diminished expression of E-cadherin, a biomarker of epithelial-mesenchymal transitions (EMT), and elevated mesenchymal markers compared with REG gamma-deficient lung cancer cells. REG gamma overexpression was found in lung cancer patients with metastasis, correlating with the reduction of E-Cadherin/Smad7 and a poor prognosis. Overall, our study indicates that REG gamma promotes lung cancer metastasis by activating TGF-beta signaling via degradation of Smad7. Thus, REG gamma may serve as a novel therapeutic target for lung cancers with poor prognosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available